In 2025, two drugs earned more than double the combined revenue of OpenAI and Anthropic and reached under 2% of the people who qualify. This is a deep dive on the biology, the economics, and where...
Cancer, heart disease, dementia, and type 2 diabetes are funded, researched, and treated as separate problems. However, they share one underlying driver...
The 60-year-old code behind $5 trillion in healthcare
The U.S. spends $5.3T a year on healthcare, yet patient medical records are often fragmented across more than 10 disconnected systems. Its core architecture has...
Deep Dive on Neuralink: Controlling Computers With Your Mind
Neuralink is pursuing one of the most difficult frontiers in technology. The implications include reversing neurological disabilities, modulating circuits involved in...
How do drugs interact with biological processes in the body? How does drug development work? Why have companies developing novel drugs seen poor returns over the past decade?
Why does the U.S. spend more on healthcare than other countries but have worse outcomes? What are the incentives that drive the behavior of insurers, hospitals and drug companies?
